HR
AVNS icon

Howe & Rusling’s Avanos Medical AVNS Stock Holding History

Howe & Rusling’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-62
Closed -$3K – 809
2019
Q1 		$3K Buy
+62
New +$2.78K ﹤0.01% 593
2018
Q1 		– Sell
-1
Closed – – 939
2017
Q4 		$0 Hold
1
– – ﹤0.01% 838
2017
Q3 		$0 Hold
1
– – ﹤0.01% 878
2017
Q2 		$0 Hold
1
– – ﹤0.01% 954
2017
Q1 		$0 Hold
1
– – ﹤0.01% 993
2016
Q4 		$0 Hold
1
– – ﹤0.01% 1023
2016
Q3 		$0 Hold
1
– – ﹤0.01% 1033
2016
Q2 		$0 Hold
1
– – ﹤0.01% 964
2016
Q1 		$0 Hold
1
– – ﹤0.01% 1005
2015
Q4 		$0 Hold
1
– – ﹤0.01% 991
2015
Q3 		$0 Hold
1
– – ﹤0.01% 1028
2015
Q2 		$0 Hold
1
– – ﹤0.01% 1054
2015
Q1 		$0 Hold
1
– – ﹤0.01% 933
2014
Q4 		$0 Buy
+1
New +$39 ﹤0.01% 902

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Howe & Rusling's AVNS Position: Q2 2019 in Review

Howe & Rusling sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 62 shares — an estimated $3K sold.

Howe & Rusling first reported a position in AVNS in Q4 2014 and held it in 14 quarters. The position peaked at $3K in Q1 2019. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Howe & Rusling reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Howe & Rusling sold 62 Avanos Medical shares in Q2 2019, an estimated $3K.
  • Howe & Rusling first reported a position in Avanos Medical in Q4 2014 and held it in 14 quarters.
  • Howe & Rusling's Avanos Medical position peaked at $3K in Q1 2019.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Howe & Rusling's 13F filing for Q2 2019, filed 12 Aug 2019.